Thailand Medicinal Cannabis Card Service Logo
Thailand cannabis regulations as of 2026
Read from the gazettes through 18 November 2026. Not a legal opinion.
LEGAL HISTORY

Medical cannabis and the first CBD limits, 2019

February 2019 opened medical cannabis research in Thailand. August 2019 is the first time a CBD percentage, 99% CBD and 0.01% THC, took something off Category 5.

Medical research, then the first CBD carve-out

Narcotics Act (No. 7), in force 19 February 2019, is the amendment that allows medical research and production under licence. It is also the day clauses 1 and 2 of the cannabis patent order end. [1] [2]

On 31 August 2019 the plant is still Category 5. Off the list: hemp as separately defined; CBD extracted from cannabis at 99% or more purity and not over 0.01% THC; a CBD-dominant extract or product at not over 0.2% THC that is a drug or a herbal product and is used as one; and dried bark, stalk core, and fibre. For five years the extract exceptions apply only to domestic production by a licensee. Hemp has the same 99% and 0.2% rules, plus non-viable seed, seed oil used as food, and seed oil or seed extract used as a cosmetic. [3]

The 14 December 2020 notification repeals that list by name. [4] [3]

InstrumentSignedGazetteIn force
1
Narcotics Act (No. 7) B.E. 2562
The amendment that opened medical research and ended clauses 1 and 2 of the NCPO patent order.
—
—
19 February 2019PDF
2
NCPO Order 1/2562
28 January 2019
Prayut Chan-o-cha
28 January 2019
136, special 25 ง, pp. 92–94
28 January 2019PDF
3
Category 5 notification (No. 2) B.E. 2562
First numeric CBD carve-out. Repealed by the 14 December 2020 list.
27 August 2019
30 August 2019
31 August 2019PDF
4
Category 5 notification B.E. 2563
Domestic extract at not over 0.2% THC, and hemp seed, leave the list. The plant stays on it.
—
14 December 2020
15 December 2020PDF
Apply for your prescription